Healthcare: The CBO Trips Up Trumpcare, Plus A Biotech “Spiffy-pop”

<p>The Congressional Budget Office announces a discouraging outlook for Trumpcare. And Portola Pharmaceuticals’ shares increase more in one day than they cost last November.</p>